Reference
Lassalle A, et al. Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared to hospital administration: results of a prospective single-center study. Annals of Oncology : 16 Nov 2015. Available from: URL: http://doi.org/10.1093/annonc/mdv563
Rights and permissions
About this article
Cite this article
Bortezomib therapy at home for MM: cost effective and preferred. PharmacoEcon Outcomes News 742, 16 (2015). https://doi.org/10.1007/s40274-015-2644-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2644-2